Akreos Ao Iol
Payments companies reported to CMS as associated with Akreos Ao Iol. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Akreos Ao Iol, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Akreos Ao Iol
These are the largest totals companies reported as associated with Akreos Ao Iol. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Cynthia Matossian | Pennington, NJ | Ophthalmology | $10,321.57 |
| Lisa Feulner | Bel Air, MD | $10,028.80 | |
| Mitchell Jackson | Lake Villa, IL | Ophthalmology | $9,607.17 |
| Inder Singh | Racine, WI | Ophthalmology | $9,504.69 |
| Parag Majmudar | Highland Park, IL | Ophthalmology | $9,426.04 |
| Patricia Stephenson | Venice, FL | Ophthalmology | $8,942.60 |
| Robert Weinstock | Largo, FL | Ophthalmology | $7,925.16 |
| Neel Desai | Largo, FL | Ophthalmology | $7,816.25 |
| Chad Hummel | Largo, FL | Ophthalmology | $5,192.64 |
| Patrick Wu | Houston, TX | Glaucoma Specialist | $2,610.37 |
Prescribed Akreos Ao Iol?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.